Skip to content

Electrodiagnostic Approach for Pectoral Nerve Conduction Studies

A New Electrodiagnostic Approach for Pectoral Nerve Conduction Studies

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06369376
Enrollment
25
Registered
2024-04-17
Start date
2023-06-30
Completion date
2024-04-12
Last updated
2024-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

New Nerve Conduction Protocol for Pectoral Nerve

Keywords

pectoral nerve, nerve conduction study, electromyography, electrodiagnostic, normative data

Brief summary

Anatomical studies have challenged traditional perceptions of the pectoral nerve structure, revealing a network of three branches rather than the previously accepted medial and lateral branches. This study aims to explore the implications of this updated anatomy on nerve conduction studies of the pectoral nerve and proposes a modified nerve conduction study protocol to enhance diagnostic accuracy. A study on 25 volunteers was conducted, examining the three parts of the pectoral nerve. Electrode placement followed a detailed methodology ensuring precise data collection. The nerve conduction study was performed bilaterally, exploring latency and amplitude while addressing inter-observer variability and demographic influences.

Interventions

DIAGNOSTIC_TESTNew nerve conduction protocol

We opted for three different recording sites, each mimicking distinct parts of the pectoral muscle, allowing for a comprehensive assessment of nerve conduction across various regions.

Sponsors

University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to 68 Years
Healthy volunteers
Yes

Inclusion criteria

\-

Exclusion criteria

* pregnancy * Pectoral nerve injury in the pas * Diabetes

Design outcomes

Primary

MeasureTime frameDescription
Latency30 minonset latency
Amplitude30 minamplitude

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026